AOP-Wiki

API

All KERs

Showing 826 to 850 of 2767 KERs

ID	Upstream Event	Downstream Event	Creation Date	Last Updated	AOPs

1188	1145: Decreased, gametogenesis	1141: Decreased, Reproductive Success	Nov 29, 2016	Dec 3, 2016	None
829	819: Decreased, Glomerular filtration	814: Occurrence, Kidney toxicity	Nov 29, 2016	Dec 3, 2016	1 AOP 128: Kidney dysfunction by decreased thyroid hormone
3234	819: Decreased, Glomerular filtration	759: Increased, Kidney Failure	Jun 6, 2024	Jun 6, 2024	1 AOP 534: Activation of Protein kinase C leads to Kidney Failure
576	578: Decreased, Glucose oxidase enzyme activity	579: Decreased, Hydrogen peroxide production	Nov 29, 2016	Dec 3, 2016	1 AOP 86: Decrease Glucose oxidase activity contributes to reduction of antiseptic in food and leads to colony loss/failure
1108	1071: Decreased, GnRH pulsatility/release in hypothalamus	1072: Decreased, LH Surge from anterior pituitary	Nov 29, 2016	Dec 3, 2016	2 AOPs 168: GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat. 169: GnRH pulse disruption leading to pituitary adenomas and carcinomas in the SD rat.
2629	1986: Decreased, Gonadotropins	1987: Decreased , Androgen and Progestin	Apr 5, 2022	Apr 5, 2022	1 AOP 445: Estrogen Receptor Alpha Agonism leads to Impaired Reproduction
154	140: Decreased, HSD17B10 expression	8: Decreased, 3-hydroxyacyl-CoA dehydrogenase type-2 activity	Nov 29, 2016	Dec 3, 2016	1 AOP 36: Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis
577	579: Decreased, Hydrogen peroxide production	580: Reduced, Antiseptic incorporated in food	Nov 29, 2016	Dec 3, 2016	1 AOP 86: Decrease Glucose oxidase activity contributes to reduction of antiseptic in food and leads to colony loss/failure
3174	2214: Decreased, INSL3	1615: Impaired inguinoscrotal phase	Mar 20, 2024	Apr 12, 2024	1 AOP 528: Decreased Insulin-like peptide 3 (INSL3) leads to Malformation, cryptorchidism - maldescended testis
2867	2121: decreased, IQ	2122: increased, Economic Burden	Apr 4, 2023	Apr 4, 2023	1 AOP 490: Co-activation of IP3R and RyR leads to socio-economic burden through reduced IQ and non-cholinergic mechanisms
1554	1416: Decreased, intracellular chloride	1355: Activated, membrane depolarization	Jun 2, 2017	Jun 2, 2017	1 AOP 231: presynaptic neuron 2 repression to epilepsy
1432	1323: Decreased, intracellular serotonin	1324: Decreased, packaged serotonin	Apr 14, 2017	Apr 14, 2017	4 AOPs 214: Network of SSRIs (selective serotonin reuptake inhibitors) 221: Mental stress to depression 222: Mental stress to agitation 226: SSRI (Selective serotonin reuptake inhibitor) to hypertension
1660	477: Decreased, Ketogenesis	327: Accumulation, Fatty acid	Aug 31, 2017	Aug 31, 2017	1 AOP 60: NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis
883	861: Decreased, Ketogenesis (production of ketone bodies)	862: Not Increased, Circulating Ketone Bodies	Nov 29, 2016	Jun 11, 2018	1 AOP 6: Antagonist binding to PPARα leading to body-weight loss
1109	1072: Decreased, LH Surge from anterior pituitary	1074: interruption, Ovulation	Nov 29, 2016	Dec 3, 2016	2 AOPs 168: GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat. 169: GnRH pulse disruption leading to pituitary adenomas and carcinomas in the SD rat.
1110	1072: Decreased, LH Surge from anterior pituitary	1075: prolonged, estrus	Nov 29, 2016	Dec 3, 2016	2 AOPs 168: GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat. 169: GnRH pulse disruption leading to pituitary adenomas and carcinomas in the SD rat.
651	635: Decreased, locomotion	588: Increased, predation	Nov 29, 2016	Dec 3, 2016	1 AOP 99: Histamine (H2) receptor antagonism leading to reduced survival
389	168: Decreased, Lymphocytes	323: Increased, Disease susceptibility	Nov 29, 2016	Dec 3, 2016	None
390	168: Decreased, Lymphocytes	403: Suppression, Immune system	Nov 29, 2016	Dec 3, 2016	1 AOP 14: Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility
2631	1988: Decreased, Maturation Inducing Steroids Surge by Granulosa cells	1989: Impaired, Oocyte maturation and ovulation	Apr 5, 2022	Apr 5, 2022	1 AOP 445: Estrogen Receptor Alpha Agonism leads to Impaired Reproduction
805	805: Decreased, mevalonate	807: Decreased, cholesterol	Nov 29, 2016	Dec 3, 2016	1 AOP 124: HMG-CoA reductase inhibition leading to decreased fertility
882	860: Decreased, Mitochondrial Fatty Acid Beta Oxidation	861: Decreased, Ketogenesis (production of ketone bodies)	Nov 29, 2016	Nov 29, 2016	None
2040	860: Decreased, Mitochondrial Fatty Acid Beta Oxidation	459: Increased, Liver Steatosis	Feb 22, 2020	Feb 22, 2020	None
2264	860: Decreased, Mitochondrial Fatty Acid Beta Oxidation	291: Accumulation, Triglyceride	Jan 15, 2021	Jan 15, 2021	1 AOP 318: Glucocorticoid Receptor activation leading to hepatic steatosis
190	179: Decreased, Mitochondrial fatty acid beta-oxidation	327: Accumulation, Fatty acid	Nov 29, 2016	Dec 3, 2016	2 AOPs 36: Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis 60: NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis

Key Event Relationships (KERs)

All KERs